Your browser doesn't support javascript.
loading
Authors' Reply to Singh and Balasundaram: Comment on "A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder".
Nasser, Azmi; Hull, Joseph T; Liranso, Tesfaye; Fry, Nicholas; Cutler, Andrew J; Rubin, Jonathan; Childress, Ann.
Affiliation
  • Nasser A; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA. anasser@supernus.com.
  • Hull JT; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA.
  • Liranso T; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA.
  • Fry N; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA.
  • Cutler AJ; Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, USA.
  • Rubin J; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA.
  • Childress A; Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas, NV, USA.
CNS Drugs ; 36(12): 1333-1335, 2022 12.
Article in En | MEDLINE | ID: mdl-36331781
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Attention Deficit Disorder with Hyperactivity / Viloxazine / Central Nervous System Stimulants / Methylphenidate Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: CNS Drugs Journal subject: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2022 Document type: Article Affiliation country: United States Country of publication: New Zealand
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Attention Deficit Disorder with Hyperactivity / Viloxazine / Central Nervous System Stimulants / Methylphenidate Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: CNS Drugs Journal subject: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2022 Document type: Article Affiliation country: United States Country of publication: New Zealand